Quantcast

Latest Americord Stories

2014-07-15 12:28:51

Hoskins Joins Leading Doctors to Help Guide Americord's Innovations in Cord Blood Banking NEW YORK, July 15, 2014 /PRNewswire/ -- Americord announced today that Iffath Abbasi Hoskins, M.D. has joined the company's Advisory Board. Dr. Hoskins is a Clinical Associate Professor in the Department of Obstetrics and Gynecology at NYU Langone Medical Center in New York City. She is a practicing obstetrician-gynecologist and a sub-specialist in maternal-fetal medicine, which focuses on...

2014-06-11 12:28:59

Americord's Significant Investment in Brooklyn Will Create New Jobs in New York NEW YORK, June 11, 2014 /PRNewswire/ -- Americord announced today that it will expand its presence in New York as a result of START-UP NY, an initiative that creates tax-free areas across New York State. Under the program, Americord will invest more than $402,000 toward a new research and development laboratory and spur the creation of new jobs. "We are thrilled to be among the first companies to take...

2014-05-27 12:33:02

Americord Yields 60% More CD34+ Stem Cells, 54% More Cord Blood, and 34% Higher TNC Than Competitors NEW YORK, May 27, 2014 /PRNewswire/ -- Americord announced today that its cord blood stem cell collection statistics beat the cord blood banking industry averages by significant margins across three critical measures. An in-depth analysis of collection samples through March 31, 2014 revealed that Americord collects 60% more CD34+ stem cells, 54% higher volume, and 34% higher total...

2014-05-16 12:27:11

Abstract Presented at ASPHO Conference by Americord's Medical Director Dr. Robert Dracker NEW YORK, May 16, 2014 /PRNewswire/ -- Breakthrough technology that harvests stem cells from the placenta was presented in an abstract written by Dr. Robert A. Dracker, Americord's Executive Medical Director, at the 27(th) annual meeting of the American Society of Pediatric Hematology/Oncology (ASPHO). The new stem cell harvesting technology enables parents to collect as many as twice the...

2014-05-05 12:28:28

Funds Will Support Research Into Safety and Efficacy of NEUROSTEM-AD® NEW YORK, May 5, 2014 /PRNewswire/ -- Americord announced today that it has provided funding to MEDIPOST, a leading stem cell biotechnology company, to support their clinical trial investigating the use of NEUROSTEM-AD® in the treatment of patients with Alzheimer's Disease. NEUROSTEM-AD® is a treatment agent for Alzheimer's Disease that uses human umbilical cord blood-derived mesenchymal stem cells. This is the...

2014-04-28 12:27:26

Americord CEO Interviewed For Article Exploring Good And Bad Practices In The Industry NEW YORK, April 28, 2014 /PRNewswire/ -- Americord Registry client Whitney Ferrarese was featured in an extensive front page Wall Street Journal article published last week about her family's positive experience with cord blood banking. Ms. Ferrarese and her husband chose Americord to store their first baby's cord blood after a long online search, and they plan to store their second baby's cord...

2014-04-14 16:25:26

Americord Raises Standards of Customer Service in Cord Blood Industry NEW YORK, April 14, 2014 /PRNewswire/ -- Cord Blood Banking leader Americord today published a bill of rights it believes every cord blood banking client should expect to receive from their cord blood bank. Encompassing information as well as service, the "Cord Blood Banking Bill of Rights" covers fundamental issues such as transparency and equitable pricing and ensures that clients who are storing their cord...

2014-04-08 12:31:24

Funds Will Support the Advancement of Cutting Edge Stem Cell Research Worldwide NEW YORK, April 8, 2014 /PRNewswire/ -- Americord announced today the launch of its corporate giving program, which will support research focused on the therapeutic uses of stem cells from umbilical cord blood, cord tissue and placenta tissue. In addition to ongoing and future clinical trials focused on a broad array of diseases, conditions, and injuries, Americord's corporate giving program may also fund...

2014-03-24 12:29:54

Americord's Quality Guarantee Remains the Highest in the Industry, Topping Cord Blood Stem Cell Banks ViaCord and CBR NEW YORK, March 24, 2014 /PRNewswire/ -- Today, less than two years after Americord implemented the highest ever quality guarantee in the cord blood banking industry at $80,000, the company has announced that it is increasing its guarantee to $90,000. Like other leading cord blood banks, Americord offers a quality guarantee to provide financial assistance to clients...

2014-03-17 12:27:21

NEW YORK, March 17, 2014 /PRNewswire/ -- Americord announced today that it has successfully resolved a trademark case brought by rival cord blood bank Cord Blood Registry (or CBR Systems Inc). In the case, which was brought before the Trademark Trial And Appeal Board of the United States Patent and Trademark Office last year, CBR opposed Americord Registry's use of the trademark CordAdvantage. "We are pleased that CBR has withdrawn its opposition to Americord's use of the trademark...


Word of the Day
sough
  • A murmuring sound; a rushing or whistling sound, like that of the wind; a deep sigh.
  • A gentle breeze; a waft; a breath.
  • Any rumor that engages general attention.
  • A cant or whining mode of speaking, especially in preaching or praying; the chant or recitative characteristic of the old Presbyterians in Scotland.
  • To make a rushing, whistling, or sighing sound; emit a hollow murmur; murmur or sigh like the wind.
  • To breathe in or as in sleep.
  • To utter in a whining or monotonous tone.
According to the OED, from the 16th century, this word is 'almost exclusively Scots and northern dialect until adopted in general literary use in the 19th.'
Related